Study of circulating tumor DNA (ctDNA) of RAS-wild metastatic colorectal cancer (mCRC) as a tool for on-site mutation screening: A prospective study.-MedSci.cn

Study of circulating tumor DNA (ctDNA) of RAS-wild metastatic colorectal cancer (mCRC) as a tool for on-site mutation screening: A prospective study.

Sawada, T; Nakamura, K; Takahashi, N; Kubota, E; Sugiyama, M; Nakano, S; Ichijo, T; Sakai, R; Numai, D; Nakanishi, H; Inagaki, S; Wakita, S; Ota, R; Hasatani, K; Tsuji, K; Doyama, H; Izawa, N; Tsuyada, A

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务